Glycogen Phosphorylase Isoenzyme Bb, Myoglobin and BNP in ANT-Induced Cardiotoxicity
Anthracyline (ANT) has been demonstrated as a useful treatment for leukemia and solid tumors. However, ANT has previously reported cardiotoxic effects, which can reduce the therapeutic index for cancer treatment. This study aimed to investigate the associations of glycogen phosphorylase isoenzyme BB...
Main Authors: | Di Jia-Yin, Zhang Zong-Xin, Xin Shao-Jun |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2018-12-01
|
Series: | Open Life Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1515/biol-2018-0067 |
Similar Items
-
Glycogen phosphorylase BB levels are associated with haemodynamic parameters in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt insertion
by: Martina Vasatova, et al.
Published: (2015-09-01) -
Studies on glycogen phosphorylase
by: Gilgan, Michael Wilson
Published: (2011) -
Regulation of glycogen phosphorylase in hypoxic cancer cells
by: Mung, Kwan-long, et al.
Published: (2015) -
The prognostic value of the NT-proBNP biomarkers and Fas ligand in assessing the risk of cardiotoxicity of anthracycline chemotherapy
by: A. T. Teplyakov, et al.
Published: (2019-03-01) -
Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines
by: Mladosievicova Beata, et al.
Published: (2012-10-01)